Overview

OC000459 Dose Finding Study in Hay Fever Sufferers.

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate a range of dose levels for efficacy in the control of symptoms of allergic rhinitis
Phase:
Phase 2
Details
Lead Sponsor:
Oxagen Ltd
Treatments:
Indoleacetic Acids